Future and perspectives

FIBROTARGETS reinforces European and International research by contributing to :

- Improve treatment outcome of patients at risk of or with HF
- Better understand of the disease and molecular mechanisms leading to MIF
- Translate research and individualized HF patient care
- Develop of novel technology as new cell-based assays for drug screening in myocardial fibrosis
- Develop of new diagnostic approaches for cardiac fibrosis and therapeutic tools targeting fibrosis
- Improve the health of European citizens